Pharmacovigilance & Post-Market Surveillance
Protecting Patients Through Continuous Monitoring
Post-market surveillance and drug safety monitoring
70%
Faster signal detection
10M+
Cases processed annually
45+
Countries covered
100%
Regulatory compliance
The Challenge
Post-market drug safety monitoring requires processing vast amounts of data from diverse sources to identify signals early. Delayed detection of safety issues puts patients at risk and can lead to costly recalls. Traditional manual methods cannot keep pace with data volume.
Our Solution
Our surveillance platform aggregates data from multiple sources and uses AI to detect safety signals faster and more accurately. By combining real-world data with advanced analytics, we enable proactive safety management throughout the product lifecycle.
Features
Key Capabilities
Multi-source Aggregation
Integrate data from EHRs, claims, social media, and literature
AI Signal Detection
Machine learning algorithms identify emerging safety patterns
Automated Reporting
Generate regulatory-compliant adverse event reports
RWE Integration
Leverage real-world evidence for comprehensive safety profiles
Compliance Tools
Stay current with evolving global regulatory requirements
Risk-Benefit Dashboard
Visualize and communicate safety data to stakeholders
Applications
Use Cases
Adverse Event Monitoring
Continuous surveillance for unexpected safety signals
DDI Detection
Identify drug-drug interactions from real-world data
Label Updates
Support evidence-based labeling decisions
Regulatory Submissions
Prepare periodic safety update reports efficiently
Ready to Get Started?
Let's discuss how Pharmacovigilance & Post-Market Surveillance can transform your organization.